Kevin M. Fain

How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider

Tony Tse, Kevin M. Fain, Deborah A. Zarin · BMJ · 2018 · 197 citations · Full text

Nursing, Biomedical Informatics, Clinical Sciences +17

10-Year Update on Study Results Submitted to ClinicalTrials.gov

Deborah A. Zarin, Kevin M. Fain, Heather D. Dobbins et al. · New England Journal of Medicine · 2019 · 152 citations · Full text

Medicine, Clinical Sciences, Clinical Medicine +14

Race and ethnicity reporting for clinical trials in ClinicalTrials.gov and publications

Kevin M. Fain, Julianne Nelson, Tony Tse et al. · Contemporary Clinical Trials · 2020 · 71 citations · Full text

Pharmacy, Biostatistics, Clinical Trial Regulation +11

The Food and Drug Administration Amendments Act and Postmarketing Commitments

Kevin M. Fain, Matthew Daubresse, G. Caleb Alexander · JAMA · 2013 · 60 citations

Law, Health Law, Pharmaceutical Policy +11

Benefits and harms of roflumilast in moderate to severe COPD

Tsung Yu, Kevin M. Fain, Cynthia M. Boyd et al. · Thorax · 2013 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14